🔗 Share this article

A shadow economy for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison.

Platform Response and Material Elimination

According to the social media company, the platform has removed violative material and banned related keywords and search suggestions. The company stated it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of weight loss, glowing reviews and detailed guides for mixing or administering at residence.

After moments of joining one group, a vendor shared contact information, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Product Information and Costs

Within these communities, messages show dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to potentially serious health risks”.